Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lionel Loubaki has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Viroelixir Exhibits Cell-Line-Specific Anticancer Activity and Enhances Chemosensitivity in Oral Squamous Cell Carcinoma: Associated Changes in Apoptosis, Redox Homeostasis, and Oncogenic Signaling

    by Manal Dahdah, Mahmoud Rouabhia, Hawraa Issa, Lionel Loubaki, Latifa Koussih, Mikhlid H. Almutairi, Abdelhabib Semlali

    Oral squamous cell carcinoma (OSCC) remains a major global health burden despite advances in surgery, radiotherapy, and chemotherapy. The development of novel therapeutic agents with improved efficacy and reduced toxicity is therefore urgently needed. This study investigated the anticancer potential of Viroelixir, a natural formulation derived from green tea and pomegranate extracts and explored its underlying molecular mechanisms in oral cancer cells. Human gingival squamous cell carcinoma cells (Ca9-22), tongue squamous cell carcinoma cells (CAL-27 and SCC-9), and non-tumorigenic oral epithelial cells (GMSM-K) were exposed to serial dilutions of Viroelixir. Cell viability, membrane damage, clonogenic survival, apoptosis, autophagy, redox status, migration, protein expression, and responses to cisplatin or 5-fluorouracil (5-FU) were assessed using MTT and LDH assays, crystal-violet staining, flow cytometry, and wound-healing assays. Viroelixir preferentially reduced Ca9-22 viability and clonogenic survival while having limited effects on GMSM-K, CAL-27, and SCC-9SCC-9 viability over 24 h of Viroelixir exposure. In Ca9-22 cells, Viroelixir increased p21, p27, and p53 and reduced Cyclin D1, a profile consistent with inhibition of G1/S progression. It promoted mitochondrial apoptosis, reduced autophagy-associated signals and LC3B expression, increased intracellular ROS and mitochondrial superoxide, depleted glutathione, and reduced wound closure while increasing E-cadherin and reducing fibronectin. Viroelixir also reduced phosphorylation of p38, ERK1/2, STAT3, NF-kappaB, and AKT1. In addition, Viroelixir enhanced the antiproliferative effects of cisplatin and 5-fluorouracil. Viroelixir exhibits a pronounced cell-line-specific anticancer response, with Ca9-22 gingival carcinoma cells displaying substantially greater sensitivity than the other oral cell models tested. This response is associated with coordinated changes in cell-cycle regulatory proteins, mitochondrial apoptosis, autophagy-associated signals, redox homeostasis, and oncogenic signaling. Viroelixir also enhances the antiproliferative effects of cisplatin and 5-FU, supporting further investigation of this formulation in OSCC. These findings support its potential development as a novel adjuvant therapeutic agent for gingival squamous cell carcinoma management.

  • Open Access

    Mitochondrial dysfunction and autophagy activation underlie NK cell impairment induced by Cannabis

    by Andrée-Ann Bolduc, Tony Tremblay, Mikhlid H. Almutairi, Abdelhabib Semlali, Lionel Loubaki

    Cannabis use continues to rise in Canada, prompting concerns due to its potential impact on immune function. This study investigated the effect of a cannabis joint extract (CJE) on natural killer (NK) cells and explored the mechanisms underlying its potential anti-inflammatory properties. Peripheral blood mononuclear cells (PBMCs) were exposed to varying concentrations of CJE to assess cytotoxicity. Flow cytometry was employed to evaluate oxidative stress, autophagy, mitochondrial membrane potential, caspase-3 activation, and DNA damage. Additionally, NK cell cytotoxicity, migration, and adhesion were analyzed. Data indicated that CJE exposure led to dose-dependent cytotoxicity in NK cells, primarily through apoptosis. Specifically, at a concentration of 3 μg/mL, CJE significantly increased reactive oxygen species (ROS), autophagy markers, caspase activation, and DNA damage, while reducing mitochondrial membrane potential. Moreover, CJE impaired NK cell-mediated killing of HeLa cells, though their migratory and adhesive abilities were unaffected. These findings evidence that cannabis can detrimentally affect NK cell viability and function via mechanisms involving autophagy and caspase-dependent apoptosis.

  • Open Access

    Selective Targeting of Senescent FHs74Int Cells by Human Breast Milk Free Fatty Acids

    by Tony Tremblay, Lionel Loubaki

    Cellular senescence is a state of irreversible growth arrest characterized by a pro-inflammatory phenotype, playing dual roles in development. In the fetal intestine, the regulation of senescent cells is critical for maintaining tissue homeostasis. Human breast milk (HBM), known for its rich composition of bioactive molecules, may play a role in modulating senescence, although its effects on senescent intestinal cells remain unexplored. This study investigated whether HBM selectively eliminates senescent cells in the FHs74Int fetal intestinal epithelial cell line. Senescence was assessed via β-galactosidase activity and expression of p16 and p21. The model cell line was treated with HBM, infant formula, and milk fractions, and outcomes included cell recovery, senescence markers, apoptosis, and mitochondrial potential. Total free fatty acids (FFA) were quantified and correlated with senolytic activity. HBM reduced senescent cell recovery without affecting non-senescent cells, correlating with decreased β-galactosidase activity, reduced phospho-p38 and γH2AX expression, mitochondrial depolarization, and caspase activation. Only the lipid fraction retained senolytic activity, which was associated with elevated FFA levels. Incubation of HBM at 37 °C increased FFA content and conferred senolytic activity. These findings are consistent with the idea that HBM exerts selective senolytic effects via FFA, revealing a novel mechanism by which breast milk could contribute to intestinal homeostasis.

  • In vitro exposure of whole blood to a cannabinoid mixture impairs the quality of red blood cells and platelets

    by Marie-Claude Lampron, Clemence Desbiens-Tremblay, Lionel Loubaki

    Background -In a recent study, 13.8% of blood donors had reported cannabis use in the 72 hours preceding their donation, and these donors are not deferred under existing criteria in Canada. This high prevalence raises concerns about the potential impact of cannabis use on the quality of blood products. The current study assessed the impact of a cannabinoid mixture on the quality of red blood cells and platelets, from the time of collection and processing to their storage. Materials and methods -To mimic pre-donation cannabis use, whole blood was collected and exposed (in vitro) to varying concentrations (range: 1-24 & mu;g/mL) of a cannabinoid mixture (CM) overnight. Whole blood was then separated into red blood cells (RBCs) and platelets-rich plasma (PRP), which were stored at 4 & DEG;C (for RBCs) or at room temperature (for PRP). Flow cytometry analyses, hemolysis measurements and biochemical analyses were performed during the processing stage and throughout storage. Results -In the RBC fraction, free hemoglobin levels were increased in a dose-dependent manner after the addition of a cannabinoid mixture to whole blood. Hemolysis and methemoglobin levels were significantly higher in CM-exposed RBCs than CM-free controls, after processing and throughout storage. Furthermore, platelet counts and CD62P expression (on day 7 post-separation) were significantly lower in CM-exposed PRP than cannabinoid-free PRP controls. The aggregation potential of CM-exposed platelets was significantly lower than that of cannabinoid-free controls, after the processing and throughout storage. Discussion -An in vitro exposure to a cannabinoid mixture hemolyzed RBCs, impaired oxygen transport by RBCs, reduced platelet counts, and impaired platelet function. These results suggest that pre-donation cannabis use might impair the quality of blood products.


  • Open Access

    Cannabinoid Mixture Affects the Fate and Functions of B Cells through the Modulation of the Caspase and MAP Kinase Pathways

    by Marie-Claude Lampron, Isabelle Paré, Mohammed Al-Zharani, Abdelhabib Semlali, Lionel Loubaki

    Cannabis use is continuously increasing in Canada, raising concerns about its potential impact on immunity. The current study assessed the impact of a cannabinoid mixture (CM) on B cells and the mechanisms by which the CM exerts its potential anti-inflammatory properties. Peripheral blood mononuclear cells (PBMCs) were treated with different concentrations of the CM to evaluate cytotoxicity. In addition, flow cytometry was used to evaluate oxidative stress, antioxidant levels, mitochondrial membrane potential, apoptosis, caspase activation, and the activation of key signaling pathways (ERK1/2, NF-κB, STAT5, and p38). The number of IgM- and IgG-expressing cells was assessed using FluoroSpot, and the cytokine production profile of the B cells was explored using a cytokine array. Our results reveal that the CM induced B-cell cytotoxicity in a dose-dependent manner, which was mediated by apoptosis. The levels of ROS and those of the activated caspases, mitochondrial membrane potential, and DNA damage increased following exposure to the CM (3 µg/mL). In addition, the activation of MAP Kinase, STATs, and the NF-κB pathway and the number of IgM- and IgG-expressing cells were reduced following exposure to the CM. Furthermore, the exposure to the CM significantly altered the cytokine profile of the B cells. Our results suggest that cannabinoids have a detrimental effect on B cells, inducing caspase-mediated apoptosis.


  • Open Access

    Oxidative Stress and Autophagy Mediate Anti-Cancer Properties of Cannabis Derivatives in Human Oral Cancer Cells

    by Lionel Loubaki, Mahmoud Rouabhia, Mohamed Al Zahrani, Abdullah Al Amri, Abdelhabib Semlali

    Cannabinoids, the active components of cannabis exert palliative effects in cancer patients by preventing nausea, vomiting and pain as well as by stimulating appetite. Recent studies indicated that cannabinoids could be helpful in treating certain rare forms of cancer and other inflammatory diseases. The objective of this study was to investigate the cytotoxic effect of a cannabinoid mixture (CM) in oral cells. Thus, normal and cancer gingival cells were treated with different concentrations of CM to evaluate their proliferation by MTT assay, cytotoxicity by using LDH assay, colony formation with crystal violet and migration by the scratch method. In addition, apoptosis, autophagy, oxidative stress, antioxidant level, DNA damage and the mitochondrial membrane potential (ΔΨm) generated by proton pumps were measured by flow cytometry. Furthermore, deactivation of the key signaling pathways involved in cancer progression such as NF-κB, ERK1/2, p38, STAT1, STAT3, STAT5 was also evaluated by this technique. These outcomes indicate that CM, at a concentration higher than 0.1 µg/mL, provokes high cytotoxicity in Ca9-22 oral cancer cells but not in GMSM-K gingival normal cells. Apoptosis, autophagy, antioxidant levels and mitochondrial stress as well as DNA damage in oral cells were increased following exposure to low concentration (1 µg/mL). In addition, major signaling pathways that are involved such as MAPKase, STATs and NF-κB pathways were inhibited by CM as well as cell migration. Our results suggest that cannabinoids could potentially have a beneficial effect on oral cancer therapy.


  • Open Access

    Blood Endothelial-Cell Extracellular Vesicles as Potential Biomarkers for the Selection of Plasma in COVID-19 Convalescent Plasma Therapy

    by Nada Amri, Nolwenn Tessier, Rémi Bégin, Laurent Vachon, Philippe Bégin, Renée Bazin, Lionel Loubaki, Catherine Martel

    Despite the advancement of vaccination and therapies currently available, deaths due to the coronavirus disease 2019 (COVID-19) are still heavily documented. Severely infected individuals experience a generalized inflammatory storm, caused by massive secretion of pro-inflammatory cytokines that can lead to endothelial dysfunction, cardiovascular disease, multi-organ failure, and even death. COVID-19 convalescent plasma (CCP) therapy, selected primarily based on anti-SARS-CoV-2 antibody levels, has not been as convincing as expected in the fight against COVID-19. Given the consequences of a dysfunctional endothelium on the progression of the disease, we propose that the selection of plasma for CCP therapy should be based on more specific parameters that take into consideration the effect on vascular inflammation. Thus, in the present study, we have characterized a subset of CCP that have been used for CCP therapy and measured their anti- or pro-inflammatory effect on human coronary artery endothelial cells (HCAECs). Our data revealed that the longer the time lapse between the onset of symptoms and the plasma donation, the more mitochondrial dysfunction can be evidenced. The concentration of blood endothelial cell extracellular vesicles (BEC-EVs) was increased in the plasma of young individuals with mild symptoms. This type of selected convalescent plasma promoted the activation of the blood vascular endothelium, as reflected by the overexpression of ICAM1 and NFκB1 and the downregulation of VE-Cadherin. We propose this mechanism is a warning signal sent by the injured endothelium to trigger self-defense of peripheral blood vessels against excessive inflammation. Therefore, these results are in line with our previous data. They suggest that a more specific selection of COVID-19 convalescent plasma should be based on the time of donation following the onset of the clinical symptoms of the donor, the severity of the symptoms, and the age of the donor. These characteristics are relatively easy to identify in any hospital and would reflect the concentration of plasma BEC-EVs and be optimal in CCP therapy.


  • Open Access

    Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells

    by Nada Amri, Rémi Bégin, Nolwenn Tessier, Laurent Vachon, Louis Villeneuve, Philippe Bégin, Renée Bazin, Lionel Loubaki, Catherine Martel

    Convalescent plasma therapy (CPT) has gained significant attention since the onset of the coronavirus disease 2019 (COVID-19) pandemic. However, clinical trials designed to study the efficacy of CPT based on antibody concentrations were inconclusive. Lymphatic transport is at the interplay between the immune response and the resolution of inflammation from peripheral tissues, including the artery wall. As vascular complications are a key pathogenic mechanism in COVID-19, leading to inflammation and multiple organ failure, we believe that sustaining lymphatic vessel function should be considered to define optimal CPT. We herein sought to determine what specific COVID-19 convalescent plasma (CCP) characteristics should be considered to limit inflammation-driven lymphatic endothelial cells (LEC) dysfunction. CCP donated 16 to 100 days after the last day of symptoms was characterized and incubated on inflammation-elicited adult human dermal LEC (aHDLEC). Plasma analysis revealed that late donation correlates with higher concentration of circulating pro-inflammatory cytokines. Conversely, extracellular vesicles (EVs) derived from LEC are more abundant in early donated plasma (r = −0.413, p = 0.004). Thus, secretion of LEC-EVs by an impaired endothelium could be an alarm signal that instigate the self-defense of peripheral lymphatic vessels against an excessive inflammation. Indeed, in vitro experiments suggest that CCP obtained rapidly following the onset of symptoms does not damage the aHDLEC junctions as much as late-donated plasma. We identified a particular signature of CCP that would counteract the effects of an excessive inflammation on the lymphatic endothelium. Accordingly, an easy and efficient selection of convalescent plasma based on time of donation would be essential to promote the preservation of the lymphatic and immune system of infected patients.


  • Open Access

    Testing for the presence of SARS‐CoV‐2 RNA in presymptomatic blood donors

    by Lionel Loubaki, Pierre Gantner, Amélie Pagliuzza, Hugues Fausther‐Bovendo, Gary Kobinger, Nicolas Chomont, Marc Germain


  • Short‐Term exposure of umbilical cord blood CD34+ cells to human platelet lysate and cytokines enhances engraftment

    by Marie‐Ève Rhéaume, Pascal Rouleau, Tony Tremblay, Isabelle Paré, Lionel Loubaki

    Background: Intra bone marrow (IBM) injection has been proposed as a strategy to bypass homing inefficiencies associated with intravenous (IV) hematopoietic progenitor stem cell (HSPC) transplantation and thus increases the number of HSPC that engraft. Despite physical delivery into the bone marrow cavity, many donor cells are rapidly redistributed by vascular perfusion. Thus, the objective of our study was to evaluate the ability of human platelet lysates (hPL) to improve HSPC retention into the bone marrow and consequently to improve engraftment.Study Design and Methods: HSPC were isolated from human umbilical cord blood. HSPC were seeded in the wells of a 24‐well microplate and exposed to increasing concentrations of hPL with or without cytokines for 24 hours. Following priming, HSPC cells chemotaxis to rhSDF‐1 was determined in vitro and engraftment in NSG mice was evaluated.Results: Priming of cord blood CD34+ cells to a combination of hPL and cytokines resulted in a significant increase (up to 3‐fold) in the expression of the CD34 antigen on HSPC. This effect was closely correlated to a significantly increased (up to 7‐fold) migration toward a rhSDF‐1 concentration gradient. In addition, IBM injection of CD34+ cells previously primed with hPL+cytokines into NSG mice showed significantly increased engraftment as measured by human platelet numbers, human CD45 and human CD34+ cells for unprimed and primed cells, respectively.Conclusion: The use of hPL + cytokines as a short‐term priming treatment for UCB could be an advantageous strategy to improve clinical outcomes following IBM injection.